Chapter 15
Pharmacotherapy of Depression and Anxiety Disorders
Depression: Überblick
Depression is a common mental illness that manifests as major depression, persistent depressive disorder, and bipolar I and II disorders.
It can be ...
Antidepressiva: Übersicht
Antidepressant drugs alleviate symptoms of depression by enhancing neurotransmission in the brain.
These agents are classified based on their chemical ...
Antidepressiva: Trizyklika, SSRIs und SNRIs
Tricyclic antidepressants, or TCAs, are first-generation antidepressants.
They block serotonin and norepinephrine reuptake transporters while inhibiting ...
Antidepressiva: MAO-Hemmer und andere Wirkstoffe
Monoamine oxidase inhibitors, or MAOIs, inhibit monoamine oxidase, increasing neurotransmitter levels.
Atypical antidepressants encompass drugs with ...
Parkinson-Krankheit: Überblick
Neurodegenerative disorders are progressive conditions characterized by the irreversible loss of neurons in specific brain regions.
The primary ...
Parkinson-Krankheit: Behandlung
Parkinson's Disease or PD is a neurodegenerative disorder characterized by an imbalance between cholinergic and reduced dopaminergic neurons.
The ...
Alzheimer-Krankheit: Überblick
Alzheimer's disease, or AD, is a neurodegenerative disorder primarily affecting older adults, causing impaired memory and cognitive decline through ...
Alzheimer-Krankheit: Behandlung
The goal of Alzheimer's disease or AD pharmacotherapy is to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms, ...
Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten